
Ramez N. Eskander, MD
Advertisement
Articles by Ramez N. Eskander, MD
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Long-Term OMNIVORE Data Show Durable Treatment-Free Survival in RCC
2
Phase 3 ENHANCE Trial: Magrolimab Adds Toxicity, Not Benefit, in MDS
3
Advanced Renal Cell Carcinoma: Summarizing a Practical First-Line Treatment Algorithm
4
First Patients Dosed With TLX597-Tx in Trial for mHSPC
5



